AbCellera Biologics Inc. (ABCL) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $1.5M. Most recent filing: Aug. 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 24, 2026 | Hayden Michael R Director | +$570,442 | 53,613 | +4% | No | |
|
|
||||||
| Aug. 18, 2026 | Montalbano John S. Director | +$110,300 | 10,000 | +4% | No | |
|
|
||||||
| Aug. 14, 2026 | Booth Andrew Chief Financial Officer | +$383,904 | 37,200 | +8% | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Hayden Michael R Director | +$481,033 | 46,387 | +4% | No | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 11, 2026 | Hayden Michael R Director | $0 | 50,000 | −4% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free